Back to Trades
Total Value
$23.1K
Filing Date
Jul 23, 2026
1 transaction
Grants
$23.1K
1 transaction
Trade Summary
On Jul 22, 2026, Dempsey Robert John, CHIEF EXECUTIVE OFFICER, Director, received $23.1K of OKYO Pharma Ltd (OKYO) across 1 transaction. The filing covers COMMON STOCK and reflects balanced net activity of $0. Reported prices ranged from $1.54. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- OKYO Pharma Ltd
- Ticker Symbol
- OKYO
- CIK
- 0001849296
Insider Information
- Role
- CHIEF EXECUTIVE OFFICER, Director
Filing Details
- Filing Date
- Jul 23, 2026
- Transaction Date
- Jul 22, 2026
- Accession Number
- 0001493152-26-034409
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 22, 2026 | COMMON STOCK | 15,000 | $1.54 | Grant/Award | $23.1K |
Want live alerts when Dempsey Robert John trades again?
Download Insider Trades to track OKYO, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.